期刊文献+

小鼠胚胎成纤维细胞介导的IL-12抗S-180肿瘤作用

Anti-tumor effects of mouse embryonic fibroblasts-mediated interleukin-12(IL-12) on Sarcoma 180 xenografts
下载PDF
导出
摘要 目的:将IL-12重组载体转染入小鼠成纤维细胞,研究探讨转染后的抗肿瘤作用.方法:取小鼠胚胎获得原代成纤维细胞,应用PEI法将IL-12重组载体转染到小鼠胚胎成纤维细胞,同时设对照.建立肉瘤细胞(S-180)荷瘤小鼠模型,分别接种S-180细胞.于注射瘤细胞后定期给予转染后的成纤维细胞瘤体内注射,并设对照组.于致瘤后第21日处死小鼠,测肿瘤质量;ELISA法检测小鼠血清IL-12及γ-干扰素(IFN-γ)的表达;检测NK(natural killer cells)细胞活性和脾淋巴细胞增殖情况、CD4/IFN-γ、CD8/IFN-γ双标记阳性细胞的克隆能力.结果:抑瘤率、NK细胞活性及淋巴细胞增生反应、血清IL-12、IFN-γ水平、CD4/IFN-γ及CD8/IFN-γ双标记阳性细胞的百分率均高于对照组(P<0.01).结论:转染后的IL-12重组质粒可进一步增强机体的免疫功能发挥其抗肿瘤的治疗作用. AIM : To investigate the anti-tumor effects of mouse embryonic fibroblasts-mediated interleukin-12(IL-12) on Sarcoma 180 xenografts. METHODS: The murine normal fibroblast were transfected with human IL-12 gene(FB/IL-12) by PEI. Controls were set up at the same time. The S-180 ceils were inoculated in mice subcutaneously. Then FB/IL-12 was injected in micc in the same place subcutaneously at intervals, and controls were set up. On the 21st day, tumor weight was recorded. The serum levels of IL-12 and the expression of interferon-γ (IFN-γ) in mice were detectedby EILISA. The activity of the natural killer cells (NK) and spleen lymphocyte were detected; the percentages of CD4^+ /IFN-γand CD8 +/IFN-γ double positive cells were also investiga- ted. RESULTS: The proliferation inhibition rate of FB/IL-12 group was higher than those of the controls ( P 〈 0.01 ). The activity of NK cells and proliferation of Lymphocytes, the serum levels of IL-12 and IFN-γ, the frequency of CD4+/IFN-γ and CD8 +/ IFN-γ double positive cells were also higher than controls (P 〈 0.01 ). CONCLUSION: By intensifying its immune ability, the mouse embryonic fibroblasts-mediated interleukin-12 (IL-12) on Sarcoma 180 xenografts has better anti-tumor effects.
作者 孙运芳
出处 《第四军医大学学报》 北大核心 2009年第24期2959-2962,共4页 Journal of the Fourth Military Medical University
基金 临沂市科技发展计划项目(080103055)
关键词 IL-12 成纤维细胞 S-180肉瘤 移植瘤 IL-12 fibroblasts Sarcoma-180 cancer cells tumor xenografts
  • 相关文献

参考文献10

  • 1Hwang KS, Cho WK, Yoo J, et al. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice[J]. BMC Cancer, 2005, 5(1): 51.
  • 2Coca S, Enrech S, Moreno G, et al. Evaluation of the antitumor activity of interleukin-12 in an experimental murine model of colorectal cancer induced by 1,2dimethyl-hydrazine (DMH) [ J ]. Rev Esp Enferm Dig,2005,97(9) :619 -628.
  • 3张文卿,王丽娜,刘志军,Dernard Mariameb,于红,杨忠思,于修平.用细胞因子流式细胞计数术体外检测重组人IL-12的生物学活性[J].中华微生物学和免疫学杂志,2006,26(4):383-384. 被引量:9
  • 4孙运芳,张文卿,王丽娜,于红,李丹.人IL-12重组质粒对S-180荷瘤小鼠的治疗作用[J].中华肿瘤防治杂志,2007,14(5):349-351. 被引量:9
  • 5乌新林,施琳,董培德.肿瘤相关成纤维细胞:抗肿瘤治疗的新靶点[J].国际外科学杂志,2006,33(2):154-157. 被引量:4
  • 6Yun C H, Lundgren A, Azem J, et al. Natural killer cells and Helieobacter pylori infection: bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production [ J ]. Infect Immun, 2005,73 ( 3 ) : 1482 - 1490.
  • 7Nakamori M, Iwahashi M, Nakamura M, et al. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer [ J]. Clin Cancer Res, 2003,9(6): 2357 -2365.
  • 8Yamashita Y I, Shimada M, Hasegawa H, et al. Electroration mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model [J]. Cancer Res, 2001,61 (3) : 1005 -1012.
  • 9董韬,纪红,秦逸人,金连弘,刘慧雯.昆明小鼠胚胎成纤维细胞分离培养及应用[J].解剖科学进展,2008,14(1):19-23. 被引量:7
  • 10Schuhz J, Heinzerling L, Pavlovic J, et al. Induction of long lasting cytokine effect by injection of IL-12 encoding plasmid DNA [ J]. Cancer Gene Ther, 2000,7(12) : 1557 - 1565.

二级参考文献44

  • 1招霞,孙海翔,胡娅莉,张宁媛,徐志鹏.ICR小鼠胚胎成纤维细胞的培养及饲养层的制作[J].医学研究生学报,2006,19(1):36-39. 被引量:5
  • 2张文卿,王丽娜,刘志军,Dernard Mariameb,于红,杨忠思,于修平.用细胞因子流式细胞计数术体外检测重组人IL-12的生物学活性[J].中华微生物学和免疫学杂志,2006,26(4):383-384. 被引量:9
  • 3Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature, 2001, 411(6835): 375-379.
  • 4Rubin H. Selected cell and selective microenvironment in neoplastic development. Cancer Res, 2001, 61(3): 799-807.
  • 5Kunz-Schughart LA, Knuechel R. Tumor-associated fibroblasts( part Ⅰ):active stromal participants in tumor development and progression? Histol Histopathol, 2002, 17(2): 599-621.
  • 6Micke P, Ostman A. Tumor-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer,2004, 45(Suppl 2) : S163-S175.
  • 7Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res,2001, 264(1) : 169-184.
  • 8Nakayama H, Enzan H, Miyazaki E, et al. The role of myofibrob-lasts at the tumor border of invasive colorectal adenocarcinomas. Jpn J Clin Oncol, 1998, 28(10):615-620.
  • 9Tuxhom JA, Ayala GE, Smith MJ, et al. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracelMar matrix remodeling. Clin Cancer Res, 2002, 8(9) : 2912-2923.
  • 10De Vever O, Marcel M. Role of tissue stroma in cancer cell invasion. J Pathol, 2003, 200(4): 429-477.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部